Commercialisation firm NDI Medical launches Deep Brain Innovations, based on Duke University research.

NDI Medical, a US-based commercialisation firm, has spun out Deep Brain Innovations (DBI), a biotech firm that focuses on therapy for patients with Parkinson’s disease.

DBI, based in Cleveland, will commercialise research into deep brain simulation (DBS) conducted by Professor Warren Grill at the Pratt School of Engineering at Duke University, who will become the firm’s chief scientific officer.

Dr. Grill said: “After more than a decade of research we’ve discovered a way to ‘speak’ to the area of the…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?